Latest Articles

Publication Date
Biokin Pharmaceutical Obtains Approval for Cervical, Endometrial Cancer Clinical Trial - marketscreener.com

Biokin Pharmaceutical Obtains Approval for Cervical, Endometrial Cancer Clinical Trial marketscreener.com

Published: April 28, 2025, 9:23 a.m.
Clinical Trial Participation Gaps in Endometrial Cancer - Physician's Weekly

Clinical Trial Participation Gaps in Endometrial Cancer Physician's Weekly

Published: April 8, 2025, 1:53 p.m.
Endometrial Cancer Treatment Market 2034: Clinical Trials, - openPR.com

Endometrial Cancer Treatment Market 2034: Clinical Trials, openPR.com

Published: April 4, 2025, 4:30 a.m.
NHS approves long-term daily pill for endometriosis in England - Clinical Trials Arena

NHS approves long-term daily pill for endometriosis in England Clinical Trials Arena

Published: March 14, 2025, 2:22 p.m.
Ananda Pharma's MRX1 moves closer to clinical trials - ICYMI - Proactive Investors UK

Ananda Pharma's MRX1 moves closer to clinical trials - ICYMI Proactive Investors UK

Published: Feb. 22, 2025, 5:05 a.m.
Ananda Pharma's MRX1 moves closer to clinical trials after key milestone - Proactive Investors UK

Ananda Pharma's MRX1 moves closer to clinical trials after key milestone Proactive Investors UK

Published: Feb. 20, 2025, 3:20 p.m.
Endometriosis imaging agent impresses at clinical trials - Health Imaging

Endometriosis imaging agent impresses at clinical trials Health Imaging

Published: Feb. 10, 2025, 12:39 p.m.
Endometriosis Clinical Trials and Studies 2025: EMA, PDMA, FDA - openPR

Endometriosis Clinical Trials and Studies 2025: EMA, PDMA, FDA openPR

Published: Feb. 6, 2025, 7:24 p.m.
Endometriosis Clinical Trial Pipeline Gains Momentum as 15+ Key Companies at the Forefront | DelveInsight - The Malaysian Reserve

Endometriosis Clinical Trial Pipeline Gains Momentum as 15+ Key Companies at the Forefront | DelveInsight The Malaysian Reserve

Published: Jan. 29, 2025, 11:29 p.m.
DelveInsight Business Research, LLP: Endometriosis Clinical Trial Pipeline Gains Momentum as 15+ Key Companies at the Forefront | DelveInsight - finanznachrichten.de

DelveInsight Business Research, LLP: Endometriosis Clinical Trial Pipeline Gains Momentum as 15+ Key Companies at the Forefront | DelveInsight finanznachrichten.de

Published: Jan. 29, 2025, 10:36 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!